Abiopharma

New Form 8-K - Mersana Therapeutics, Inc. Filed: 2025-07-24 AccNo: 0001104659-25-070245 Size: 212 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits